Fundly.ai raises $4M to scale pharma commerce, payments and credit network

Mumbai-based Fundly.ai has raised $4 million in pre-Series A funding and $900,000 in venture debt to deepen distributor and retailer coverage, expand its Pune pilot and enter new cities. The platform serves 4,100+ retailers across 24+ cities.

— Source publishedTue, 8 Sept, 2026, 13:08 IST·First seen Tue, 8 Sept, 2026, 13:31 IST·Source Inc42

What happened

Mumbai-based Fundly.ai raised $4 Mn pre-Series A and $900K debt to expand its pharma B2B commerce, payments and embedded-credit infrastructure. It will deepen

Key facts

  • $4 Mn (about ₹38 Cr) pre-Series A
  • $900K venture debt
  • total funding above $7 Mn
  • Pune pilot covers about 3,000 retailers
  • served more than 4,100 retailers
  • presence across 24+ cities and 600+ pin codes
  • $3 Mn seed funding in 2023
  • India pharma distribution and logistics market: $19.35 Bn in 2026, projected $25.35 Bn by 2031
  • Zeelab targets ₹200 Cr revenue in FY27
  • DocPharma raised $2 Mn

Why this matters

Fundly.ai’s funding and growing retailer-distributor footprint make it a potential partnership or acquisition target for pharma distributors, fintechs and B2B commerce platforms seeking last-mile network access.

What to watch

  • Retailer count growth, active-retailer retention and order frequency after the Pune expansion.
  • Number and quality of distributor partnerships, including exclusive or preferred-network arrangements.
  • Credit book size, repayment rates, delinquency trends and average collection period.
  • Evidence that new-city launches reach transaction density without sustained retailer incentives.
  • Follow-on financing, especially whether additional debt facilities are secured on improved underwriting performance.
  • Competitive moves by pharma distribution networks, B2B commerce platforms and embedded-lending providers.
  • Prioritize Pune pilot conversion metrics before broadening city launches.
  • Use venture debt primarily against short-duration, well-underwritten receivables rather than fixed operating costs.
  • Add distributor integrations and inventory visibility to improve order fulfilment and reduce retailer churn.
  • Build city-level credit scoring using payment behavior, reorder cadence and distributor settlement data.
  • Target pharma manufacturers and distributor groups for channel partnerships that lower retailer acquisition costs.

Also reported by